enVVeno Medical Corporation
NVNO
$2.36
-$0.12-4.84%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.78% | 25.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.57% | 13.13% | |||
| Operating Income | -8.57% | -13.13% | |||
| Income Before Tax | -10.40% | -13.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.40% | -13.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.40% | -13.84% | |||
| EBIT | -8.57% | -13.13% | |||
| EBITDA | -8.68% | -13.40% | |||
| EPS Basic | 12.96% | 5.54% | |||
| Normalized Basic EPS | 15.19% | 6.30% | |||
| EPS Diluted | 12.96% | 5.54% | |||
| Normalized Diluted EPS | 15.19% | 6.30% | |||
| Average Basic Shares Outstanding | 26.84% | 20.53% | |||
| Average Diluted Shares Outstanding | 26.84% | 20.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
